A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT00095823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Aripiprazole as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder.
Study identification
- NCT ID
- NCT00095823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 1,200 participants
Conditions and interventions
Conditions
Interventions
- Antidepressant + Placebo Drug
- Antidepressant + Aripiprazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2004
- Primary completion
- Jul 31, 2006
- Completion
- Jul 31, 2006
- Last update posted
- Nov 24, 2013
2004 – 2006
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Garden Grove | California | — | — |
| Local Institution | Northridge | California | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Edwardsville | Illinois | — | — |
| Local Institution | Rockville | Maryland | — | — |
| Local Institution | Springfield | Massachusetts | — | — |
| Local Institution | Farmington Hills | Michigan | — | — |
| Local Institution | Okemos | Michigan | — | — |
| Local Institution | Staten Island | New York | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Woodstock | Vermont | — | — |
| Local Institution | Charlottesville | Virginia | — | — |
| Local Institution | Bellevue | Washington | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Middleton | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2013 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00095823 live on ClinicalTrials.gov.